Mounjaro®
Starting from £179.99/mo
Start journey Learn moreConstipation on Wegovy is common, manageable and — for most people — temporary. Semaglutide slows the movement of food through your digestive system as part of how it works, and that slower transit can back things up, particularly in the first few weeks or after a dose increase. The good news is that practical changes to fluid intake, fibre, movement and timing resolve it for the majority of people without needing to stop treatment. These are prescription-only medicines, and a prescriber should be involved in any decision about managing persistent or severe symptoms, but the everyday steps below are evidence-based and worth starting today. Our clinical team covers side effects in full during every consultation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide, the active medicine in Wegovy, reduces appetite partly by slowing how quickly the stomach empties and food moves through the gut. That mechanism is central to how it produces weight loss, but it also means the colon has less material arriving, arriving more slowly, with more time for water to be absorbed out of it. The result, for a significant minority of people, is stools that are harder, less frequent and more difficult to pass.
This is worth knowing because it changes the decision in front of you. You are not dealing with a random side effect, you are dealing with a predictable physiological consequence that has predictable solutions. Increasing fibre without also increasing fluids, for example, can make things worse rather than better, because dry fibre absorbs the water that soft stools need. The approach that works is layered: fluid first, then fibre, then movement, with gentle osmotic support if needed.
The evidence on whether Wegovy causes constipation shows it affects roughly one in ten people in clinical trials, though real-world rates appear higher, possibly because trial participants received careful dietary coaching throughout. If you want to understand more about how Wegovy constipation develops and why it happens, that can help you respond to it proportionally, rather than assuming something has gone wrong with your treatment.
Start with water. Most people on Wegovy eat considerably less than before, which means they are also drinking less incidentally through food. Aiming for 1.5 to 2 litres of plain water daily (separate from coffee, which can mildly dehydrate) keeps stool consistency where it needs to be. A practical prompt: a large glass before the tablet or pen day, and one with every meal, gets you most of the way there without counting.
Fibre is the second lever. Soluble fibre (oats, lentils, ground flaxseed, cooked vegetables) absorbs water and forms a gel that keeps transit smooth. Insoluble fibre, found in wholegrain bread, bran and raw vegetables, adds bulk. Both help, but adding a large amount of insoluble fibre quickly, without fluid to match, can worsen bloating. A steady increase over a week or two, alongside that fluid target, is the approach supported by NHS dietary guidance.
Movement matters too. Even a 20-minute walk after meals can stimulate peristalsis, the muscular contractions that push content through the colon. Wegovy already encourages more activity as part of its licensed use alongside a reduced-calorie diet, so this serves two purposes at once. For more detailed daily approaches, the guidance on how to help constipation on Wegovy covers a practical daily framework, and if you need to know which specific remedies and interventions are appropriate, the advice on how to treat constipation on Wegovy takes you through the options in order of evidence and suitability.
One misconception worth letting go of gently: many people assume that eating less means the gut simply needs to work less, so infrequency is fine. In reality, regular transit is a sign of a healthy colon regardless of food volume, and prolonged constipation causes discomfort, bloating and can make nausea worse, a side effect Wegovy already carries risk of at dose increases.
Most constipation on Wegovy responds to the fluid, fibre and movement steps above within a week or two. If it does not, an osmotic laxative such as macrogol (available over the counter) is generally considered suitable for short-term use alongside GLP-1 medicines, your pharmacist can advise on the right product and dose for you. Stimulant laxatives should be used with more caution and ideally discussed with a prescriber first.
There are symptoms that go beyond constipation and need prompt attention. The NHS advises seeking medical help if you experience severe or persistent abdominal pain, vomiting alongside constipation that is not resolving, blood in your stool, or a complete absence of bowel movements for more than three days despite laxative use. Stomach pain that radiates to the back, particularly with vomiting, should be assessed urgently, this pattern can indicate pancreatitis, which the MHRA highlighted in a Drug Safety Update for GLP-1 medicines as a rare but serious risk requiring immediate medical review.
If constipation is making your experience of Wegovy significantly uncomfortable, that is a legitimate reason to speak to your prescriber about whether a dose pause or adjustment is appropriate. The full side-effect profile of Wegovy includes the range of gastrointestinal effects and how they are typically managed. The NHS semaglutide medicine page is also a reliable reference for what to watch for and when to act.
At nume, a GPhC-registered Independent Prescriber reviews every consultation and repeat order personally. Side-effect management is a normal part of that conversation, not an afterthought. If you are already on Wegovy and struggling with constipation, our aftercare team is available seven days a week and can facilitate a prescriber review without you needing to restart the process.
For people who are new to treatment, it is worth raising any history of constipation or bowel conditions during your initial consultation, certain underlying conditions affect how suitable GLP-1 medicines are, and a prescriber who knows your full picture is better placed to support you through the early weeks. You can read more about how Wegovy works and what treatment involves before starting, or explore treatment options if you are still deciding. Our prescribers discuss suitability and side-effect management as part of every clinical assessment, start your free consultation to speak with the team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.